
    
      In many real world, lacosamide as the first add-on therapy can significantly improve the
      seizure freedom rate. Moreover, many pharmacoeconomic studies in Sweden and the United States
      have confirmed that lacosamide is a more cost-effective option.This is a real-world study to
      evaluate the efficacy, safety and cost-effectiveness of Generic lacoxamide tablets in the
      treatment of patients with focal epilepsy. During the trial, patients with focal epilepsy
      were treated with lacosamide for the first time after the failure of the original
      antiepileptic drug. At the same time, the cost-effectiveness of Generic lacosamide was
      evaluated from the perspective of economics, in order to provide the basis for the clinical
      choice for Chinese epilepsy patients.
    
  